Testing a new long-acting insulin in type 1 diabetes
Part of Hormones & metabolism clinical trials.
This study compares a new investigational long-acting insulin (GZR33) to an approved one (insulin degludec) in people with type 1 diabetes. You would receive both insulins during an inpatient 'clamp' procedure to see how well they work, which may help find a more affordable or convenient option for daily blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 1 diabetes for at least 1 year.
- You are between 18 and 64 years old.
- Your average blood sugar (A1C) is 9.0% or lower.
- Your body mass index (BMI) is between 18.5 and 29.0.
- You have been on the same insulin routine (stable dose) for at least 2 months, using between 0.2 and 1.2 units per kilogram of body weight each day.
- You have not had more than 1 severe low blood sugar event needing help in the last 6 months, and you are aware of low blood sugar symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new once-daily insulin (GZR4) against an approved insulin (degludec) in people with type 2 diabetes to see how well it controls blood sugar. You may qualify if you are already using a stable dose of background insulin.
This study tests an investigational drug called LY3938577 in healthy people and people with type 1 diabetes. It looks at how the drug affects the body and whether it might help control blood sugar.
This study tests a new injectable medication called GZR33 to help control blood sugar in people with type 2 diabetes who are already taking oral diabetes pills. The trial will measure how well it works and how safe it is.
This trial tests an experimental insulin (GZR101-80) to see if it helps control blood sugar in people with type 2 diabetes. You may join if you’ve had type 2 diabetes for at least 6 months and are between 18 and 75 years old.
This trial tests a new weekly insulin called GZR4 for people with type 2 diabetes who already use basal insulin. It aims to see how well it controls blood sugar and if it is safe.
This study tests if a new insulin injection made with different manufacturing methods works the same in the body. Healthy men aged 18-50 can join to help check if the new versions are as good as the original.
Hear when a new Type 1 Diabetes Mellitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.